冠心病患者血清HMGA2和IGFBP2水平及对PCI术后支架内再狭窄的预测价值OA
Serum levels of HMGA2 and IGFBP2 in coronary heart disease patients and their predictive value for in-stent restenosis after percutaneous coronary intervention
目的 通过检测冠心病患者血清高迁移率族蛋白A2(HMGA2)和胰岛素样生长因子结合蛋白2(IGFBP2)水平,分析二者对患者经皮冠状动脉介入治疗(PCI)术后支架内再狭窄(ISR)的预测价值.方法 选取2019年7月至2023年7月该院收治的接受PCI的294例冠心病患者作为研究对象,根据随访1年后冠状动脉造影结果,将其分为ISR组和非ISR组;采用Gensini评分法将其分为轻度组、中度组和重度组.收集患者的基线资料.采用酶联免疫吸附试验检测所有患者血清HMGA2和IGFBP2水平.采用多因素Logistic回归分析冠心病患者PCI术后ISR的影响因素.绘制受试者工作特征(ROC)曲线分析血清HMGA2和IGFBP2对患者PCI术后ISR的预测价值.结果 ISR组50例,非ISR组244例.ISR组合并糖尿病占比及血清HM-GA2、IGFBP2、脑钠肽(BNP)水平高于非ISR组,病变支架长度长于非ISR组,差异均有统计学意义(P<0.05).轻度组27例,中度组14例,重度组9例.重度组血清HMGA2、IGFBP2水平明显高于轻度组与中度组(P<0.05),中度组血清HMGA2、IGFBP2水平明显高于轻度组(P<0.05).多因素Logistic回归分析结果显示,合并糖尿病、支架长度增加及血清BNP、HMGA2、IGFBP2水平升高均为冠心病患者PCI术后ISR的危险因素(P<0.05).ROC曲线分析结果显示,血清 HMGA2、IGFBP2单独及联合预测冠心病患者PCI术后ISR的曲线下面积(AUC)分别为0.887、0.854、0.935,血清HMGA2、IGFBP2联合预测的AUC显著大于血清HMGA2(Z=2.128,P=0.033)、IGFBP2(Z=3.323,P=0.001)单独预测的AUC.结论 冠心病PCI术后ISR患者血清HMGA2、IGFBP2水平升高,且血清HMGA2、IGFBP2对冠心病患者PCI术后ISR具有一定的预测价值.
Objective To analyze the predictive value of serum high-mobility group protein A2(HMGA2)and insulin-like growth factor-binding protein 2(IGFBP2)levels for in-stent restenosis(ISR)in coronary heart disease patients after percutaneous coronary intervention(PCI)by detecting the serum levels of HM-GA2 and IGFBP2.Methods A total of 294 coronary heart disease patients who underwent PCI in this hospital from July 2019 to July 2023 were selected as the research subjects.According to the results of coronary angi-ography after 1-year follow-up,they were divided into the ISR group and the non-ISR group;they were also di-vided into the mild group,the moderate group and the severe group using the Gensini scoring method.The baseline data of the patients were collected.The serum levels of HMGA2 and IGFBP2 in all patients were de-tected by enzyme-linked immunosorbent assay.Multivariate Logistic regression analysis was used to analyze the influencing factors of ISR after PCI.The receiver operating characteristic(ROC)curve was drawn to ana-lyze the predictive value of serum HMGA2 and IGFBP2 for ISR after PCI.Results There were 50 cases in the ISR group and 244 cases in the non-ISR group.The proportion of patients with diabetes mellitus,and the ser-um levels of HMGA2,IGFBP2 and brain natriuretic peptide(BNP)in the ISR group were higher than those in the non-ISR group,and the stent length was longer than that in the non-ISR group,with statistically signifi-cant differences(P<0.05).There were 27 cases in the mild group,14 cases in the moderate group,and 9 ca-ses in the severe group.The serum levels of HMGA2 and IGFBP2 in the severe group were significantly high-er than those in the mild and moderate groups(P<0.05),and the serum levels of HMGA2 and IGFBP2 in the moderate group were significantly higher than those in the mild group(P<0.05).The results of multiva-riate Logistic regression analysis showed that co-existing diabetes mellitus,increased stent length,and in-creased serum levels of BNP,HMGA2 and IGFBP2 were all risk factors for ISR after PCI in coronary heart disease patients(P<0.05).The results of ROC curve analysis showed that the areas under the curve(AUC)of serum HMGA2,IGFBP2 alone and in combination in predicting ISR after PCI in coronary heart disease pa-tients were 0.887,0.854 and 0.935,respectively.The AUC of the combined prediction of serum HMGA2 and IGFBP2 was significantly greater than that of serum HMGA2(Z=2.128,P=0.033)and IGFBP2(Z=3.323,P=0.001)alone.Conclusion The serum levels of HMGA2 and IGFBP2 are increased in coronary heart disease patients with ISR after PCI,and serum HMGA2 and IGFBP2 have a certain predictive value for ISR after PCI in patients with coronary heart disease.
王超;张晓红;尹璇;刘明
河北省第八人民医院:普内科,河北 石家庄 050000河北省第八人民医院:普内科,河北 石家庄 050000河北省第八人民医院:心内科,河北 石家庄 050000河北省第八人民医院:心内科,河北 石家庄 050000
医药卫生
冠心病经皮冠状动脉介入治疗高迁移率族蛋白2胰岛素样生长因子结合蛋白2支架内再狭窄预测价值
coronary heart diseasepercutaneous coronary interventionhigh mobility group protein 2insulin like growth factor binding protein 2in-stent restenosispredictive value
《检验医学与临床》 2026 (2)
164-170,7
评论